Nirmatrelvir-Ritonavir Reduces Risk For COVID-19-Related Hospitalization In Partially-Vaccinated Patients, Research Finds
June 20, 2023
Infectious Disease Advisor (6/16, Chan) reported, “Results of a study...show that treatment with nirmatrelvir-ritonavir is associated with reduced risk for COVID-19-related hospitalization among partially-vaccinated high-risk outpatients.” The findings of...